PUBLISHER: The Business Research Company | PRODUCT CODE: 1522239
PUBLISHER: The Business Research Company | PRODUCT CODE: 1522239
Kinase Inhibitors Global Market Report 2024
Kinase inhibitors are medications designed to inhibit the activity of kinases, crucial enzymes involved in cellular processes such as growth and signaling. These inhibitors are primarily utilized in cancer treatment, where they disrupt pathways responsible for cancer cell proliferation and metastasis. Additionally, kinase inhibitors find application in managing inflammatory disorders and other conditions characterized by abnormal kinase function.
The main categories of kinase inhibitors include tyrosine kinase inhibitors, multikinase inhibitors, mTOR kinase inhibitors, and others. Tyrosine kinase inhibitors specifically target enzymes known as tyrosine kinases, which play a role in cancer cell growth. These inhibitors can be administered via oral, parenteral, and other routes, catering to treatment needs in oncology and inflammatory diseases. They are distributed through various channels such as hospital pharmacies, online pharmacies, and retail outlets, serving patients in hospital settings, homecare, specialty clinics, and other healthcare environments.
The kinase inhibitors market research report is one of a series of new reports from The Business Research Company that provides kinase inhibitors market statistics, including the kinase inhibitors industry global market size, regional shares, competitors with kinase inhibitors market share, detailed kinase inhibitors market segments, market trends, and opportunities, and any further data you may need to thrive in the kinase inhibitors industry. This kinase inhibitors market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The kinase inhibitors market size has grown strongly in recent years. It will grow from $58.49 billion in 2023 to $62.75 billion in 2024 at a compound annual growth rate (CAGR) of 7.3%. The growth observed during the historic period can be attributed to several factors, including the increasing prevalence of cancer, advancements in targeted therapy approaches, rising healthcare expenditures, the approval of new kinase inhibitors, and the growing adoption of personalized medicine strategies.
The kinase inhibitors market size is expected to see strong growth in the next few years. It will grow to $83.56 billion in 2028 at a compound annual growth rate (CAGR) of 7.4%. The anticipated growth in the forecast period can be attributed to ongoing research and development initiatives, the introduction of novel kinase inhibitors, the widening scope of applications beyond oncology, increased investments in biotechnology, and heightened awareness about precision medicine. Major trends expected during this period include the expansion of precision oncology treatments, the development of combination therapies, a greater focus on rare and difficult-to-treat cancers, advancements in biomarker-driven drug development, and the increased adoption of next-generation sequencing technologies.
The rising prevalence of autoimmune diseases is expected to drive growth in the kinase inhibitors market. Autoimmune diseases encompass a range of disorders where the immune system erroneously attacks healthy cells, tissues, and organs, leading to damage. Lifestyle changes, environmental factors, genetic factors, stress, microbial imbalances, and the increasing incidence of chronic diseases such as obesity and diabetes contribute to the growing prevalence of autoimmune diseases. Kinase inhibitors offer therapeutic benefits for autoimmune conditions by modulating the immune system, reducing inflammation, and easing symptoms such as those seen in psoriatic and rheumatoid arthritis. For example, as of December 2022, the National Psoriasis Foundation reported over 8 million cases of psoriasis in the United States and 125 million globally, affecting about 2 to 3% of the population. Additionally, in September 2022, the Centers for Disease Control and Prevention stated that 28.7 million people in the US had diabetes, with 5.7% requiring insulin for type 1 diabetes. This increase in autoimmune disease instances is thus fueling the growth of the kinase inhibitors market.
Leading companies in the kinase inhibitors sector are focusing on developing selective tyrosine kinase 2 (TYK2) inhibitors to meet the demand for treating autoimmune and inflammatory diseases. These inhibitors also play a role in cancer treatment by modulating immune responses, reducing inflammation, and creating an unfavorable environment for tumor growth. For instance, in September 2022, Bristol-Myers Squibb Company gained FDA approval for Sotyktu (deucravacitinib), an oral selective TYK2 inhibitor for treating moderate-to-severe plaque psoriasis in adults needing systemic therapy or phototherapy. This approval signifies a significant step forward in addressing plaque psoriasis, offering a new option for patients with inadequate responses to current treatments.
In August 2022, Bristol Myers Squibb acquired Turning Point Therapeutics Inc. for $4.1 billion, strengthening its position in kinase inhibitors. This acquisition included late-stage kinase inhibitor candidate repotrectinib, expanding BMS's precision oncology portfolio and enhancing its capabilities in treating ROS1-positive non-small cell lung cancer (NSCLC) and other solid tumors. Turning Point Therapeutics Inc. is known for designing and developing small-molecule tyrosine kinase inhibitors (TKIs).
Major companies operating in the kinase inhibitors market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd, Merck & Co. Inc., Bristol-Myers Squibb Company, AstraZeneca Plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd, Astellas Pharma Inc, Cipla Inc, Dr. Reddy's Laboratories Ltd, Endo International Inc., Amneal Pharmaceuticals LLC, Lupin Limited, Exelixis Inc, Glenmark Pharmaceuticals Ltd, Torrent Pharmaceuticals Ltd, Hutchison China MediTech Limited, Akorn Incorporated, Ocular Therapeutix Inc., Sierra Oncology Inc
Asia-Pacific was the largest region in the kinase inhibitors market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the kinase inhibitors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the kinase inhibitors market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The kinase inhibitors market consists of sales of BCR-ABL Inhibitors, ALK Inhibitors, lapatinib, cabozantinib, and sunitinib. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Kinase Inhibitors Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on kinase inhibitors market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
- Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
- Measure the impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for kinase inhibitors ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The kinase inhibitors market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
The impact of higher inflation in many countries and the resulting spike in interest rates.
The continued but declining impact of COVID-19 on supply chains and consumption patterns.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Type: Tyrosine Kinase Inhibitors; Multikinase Inhibitors; mTOR Kinase Inhibitors; Other Types
- 2) By Route of Administration: Oral; Parenteral; Other Routes
- 3) By Application: Oncology; Inflammatory Diseases
- 4) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy
- 5) By End User: Hospitals; Homecare; Specialty Clinics; Other End-Users
- Companies Mentioned: Pfizer Inc.; Johnson & Johnson; F. Hoffmann-La Roche Ltd; Merck & Co. Inc.; Bristol-Myers Squibb Company
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Kinase Inhibitors Market Characteristics
3. Kinase Inhibitors Market Trends And Strategies
4. Kinase Inhibitors Market - Macro Economic Scenario
- 4.1. Impact Of High Inflation On The Market
- 4.2. Ukraine-Russia War Impact On The Market
- 4.3. COVID-19 Impact On The Market
5. Global Kinase Inhibitors Market Size and Growth
- 5.1. Global Kinase Inhibitors Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
- 5.2. Global Kinase Inhibitors Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
- 5.3. Global Kinase Inhibitors Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)
6. Kinase Inhibitors Market Segmentation
- 6.1. Global Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- Tyrosine Kinase Inhibitors
- Multikinase Inhibitors
- Mammalian Target Of Rapamycin (mTOR) Kinase Inhibitors
- Other Types
- 6.2. Global Kinase Inhibitors Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- Oral
- Parenteral
- Other Routes
- 6.3. Global Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- Oncology
- Inflammatory Diseases
- 6.4. Global Kinase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
- 6.5. Global Kinase Inhibitors Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- Hospitals
- Homecare
- Specialty Clinics
- Other End-Users
7. Kinase Inhibitors Market Regional And Country Analysis
- 7.1. Global Kinase Inhibitors Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 7.2. Global Kinase Inhibitors Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8. Asia-Pacific Kinase Inhibitors Market
- 8.1. Asia-Pacific Kinase Inhibitors Market Overview
- Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 8.3. Asia-Pacific Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 8.4. Asia-Pacific Kinase Inhibitors Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
9. China Kinase Inhibitors Market
- 9.1. China Kinase Inhibitors Market Overview
- 9.2. China Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
- 9.3. China Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
- 9.4. China Kinase Inhibitors Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
10. India Kinase Inhibitors Market
- 10.1. India Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 10.2. India Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 10.3. India Kinase Inhibitors Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11. Japan Kinase Inhibitors Market
- 11.1. Japan Kinase Inhibitors Market Overview
- 11.2. Japan Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 11.3. Japan Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 11.4. Japan Kinase Inhibitors Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12. Australia Kinase Inhibitors Market
- 12.1. Australia Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 12.2. Australia Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 12.3. Australia Kinase Inhibitors Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13. Indonesia Kinase Inhibitors Market
- 13.1. Indonesia Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 13.2. Indonesia Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 13.3. Indonesia Kinase Inhibitors Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14. South Korea Kinase Inhibitors Market
- 14.1. South Korea Kinase Inhibitors Market Overview
- 14.2. South Korea Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 14.3. South Korea Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 14.4. South Korea Kinase Inhibitors Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15. Western Europe Kinase Inhibitors Market
- 15.1. Western Europe Kinase Inhibitors Market Overview
- 15.2. Western Europe Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 15.3. Western Europe Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 15.4. Western Europe Kinase Inhibitors Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16. UK Kinase Inhibitors Market
- 16.1. UK Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 16.2. UK Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 16.3. UK Kinase Inhibitors Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17. Germany Kinase Inhibitors Market
- 17.1. Germany Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 17.2. Germany Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 17.3. Germany Kinase Inhibitors Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18. France Kinase Inhibitors Market
- 18.1. France Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 18.2. France Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 18.3. France Kinase Inhibitors Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19. Italy Kinase Inhibitors Market
- 19.1. Italy Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 19.2. Italy Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 19.3. Italy Kinase Inhibitors Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20. Spain Kinase Inhibitors Market
- 20.1. Spain Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 20.2. Spain Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 20.3. Spain Kinase Inhibitors Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21. Eastern Europe Kinase Inhibitors Market
- 21.1. Eastern Europe Kinase Inhibitors Market Overview
- 21.2. Eastern Europe Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 21.3. Eastern Europe Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 21.4. Eastern Europe Kinase Inhibitors Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22. Russia Kinase Inhibitors Market
- 22.1. Russia Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 22.2. Russia Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 22.3. Russia Kinase Inhibitors Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23. North America Kinase Inhibitors Market
- 23.1. North America Kinase Inhibitors Market Overview
- 23.2. North America Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 23.3. North America Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 23.4. North America Kinase Inhibitors Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24. USA Kinase Inhibitors Market
- 24.1. USA Kinase Inhibitors Market Overview
- 24.2. USA Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 24.3. USA Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 24.4. USA Kinase Inhibitors Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25. Canada Kinase Inhibitors Market
- 25.1. Canada Kinase Inhibitors Market Overview
- 25.2. Canada Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 25.3. Canada Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 25.4. Canada Kinase Inhibitors Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26. South America Kinase Inhibitors Market
- 26.1. South America Kinase Inhibitors Market Overview
- 26.2. South America Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 26.3. South America Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 26.4. South America Kinase Inhibitors Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27. Brazil Kinase Inhibitors Market
- 27.1. Brazil Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 27.2. Brazil Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 27.3. Brazil Kinase Inhibitors Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28. Middle East Kinase Inhibitors Market
- 28.1. Middle East Kinase Inhibitors Market Overview
- 28.2. Middle East Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 28.3. Middle East Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 28.4. Middle East Kinase Inhibitors Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29. Africa Kinase Inhibitors Market
- 29.1. Africa Kinase Inhibitors Market Overview
- 29.2. Africa Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 29.3. Africa Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 29.4. Africa Kinase Inhibitors Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
30. Kinase Inhibitors Market Competitive Landscape And Company Profiles
- 30.1. Kinase Inhibitors Market Competitive Landscape
- 30.2. Kinase Inhibitors Market Company Profiles
- 30.2.1. Pfizer Inc.
- 30.2.1.1. Overview
- 30.2.1.2. Products and Services
- 30.2.1.3. Strategy
- 30.2.1.4. Financial Performance
- 30.2.2. Johnson & Johnson
- 30.2.2.1. Overview
- 30.2.2.2. Products and Services
- 30.2.2.3. Strategy
- 30.2.2.4. Financial Performance
- 30.2.3. F. Hoffmann-La Roche Ltd
- 30.2.3.1. Overview
- 30.2.3.2. Products and Services
- 30.2.3.3. Strategy
- 30.2.3.4. Financial Performance
- 30.2.4. Merck & Co. Inc.
- 30.2.4.1. Overview
- 30.2.4.2. Products and Services
- 30.2.4.3. Strategy
- 30.2.4.4. Financial Performance
- 30.2.5. Bristol-Myers Squibb Company
- 30.2.5.1. Overview
- 30.2.5.2. Products and Services
- 30.2.5.3. Strategy
- 30.2.5.4. Financial Performance
- 30.2.1. Pfizer Inc.
31. Kinase Inhibitors Market Other Major And Innovative Companies
- 31.1. AstraZeneca Plc
- 31.2. Abbott Laboratories
- 31.3. Novartis AG
- 31.4. GlaxoSmithKline PLC
- 31.5. Takeda Pharmaceutical Company Limited
- 31.6. Eli Lilly and Company
- 31.7. Teva Pharmaceutical Industries Ltd
- 31.8. Astellas Pharma Inc
- 31.9. Cipla Inc
- 31.10. Dr. Reddy's Laboratories Ltd
- 31.11. Endo International Inc.
- 31.12. Amneal Pharmaceuticals LLC
- 31.13. Lupin Limited
- 31.14. Exelixis Inc
- 31.15. Glenmark Pharmaceuticals Ltd
32. Global Kinase Inhibitors Market Competitive Benchmarking
33. Global Kinase Inhibitors Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Kinase Inhibitors Market
35. Kinase Inhibitors Market Future Outlook and Potential Analysis
- 35.1 Kinase Inhibitors Market In 2028 - Countries Offering Most New Opportunities
- 35.2 Kinase Inhibitors Market In 2028 - Segments Offering Most New Opportunities
- 35.3 Kinase Inhibitors Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
